Treatment of Inflamed Pterygium and Pinguecula with Topical Indomethacin 0.1% Solution. Frucht-Pery, J. M. D., Solomon, A. M. D., Siganos, C. S. M. D., Shvartzenberg, T. M. D., Richard, C. M. D., & Trinquand, C. M. D. Cornea, 16(1):42–47, January, 1997.
abstract   bibtex   
Purpose. To evaluate the effect of topical indomethacin 0.1% on signs and symptoms in inflamed pterygium and pinguecula. Methods. Fifty-one consecutive patients who had inflamed pterygium (n = 32) or pinguecula (n = 19) were studied in a randomized, double-masked, controlled way. Objective signs (conjunctival congestion, redness, edema, and staining of cornea) and subjective complaints (photophobia, pain, foreign-body sensation, discomfort, and tearing) were evaluated and scored. In addition, we evaluated total signs, total symptoms, and total score. Group I (n = 25) received topical indomethacin 0.1% solution and group 2 (n = 26) received a placebo six times daily for 3 days, then four times daily for 11 days. Patients were examined before and at days 3, 7, and 14 after the treatment began. Results. In group 1 at day 3, the scores of total signs, total symptoms, and total score decreased (p = 0.001), and they further decreased after 14 days (p = 0.02 to p = 0.05). In group 2 at day 3 these parameters also significantly decreased (p = 0.01 to p = 0.02), but no further improvement occurred after 14 days. Comparing groups I and 2 revealed a decrease in scores in group 1 for total signs, total symptoms, and total score at days 3, 7, and 14 (p = 0.03 to p = 0.002) except for total signs after 14 days (p = NS). All the patients reported mild stinging for \textless1 min after administration of the drops. Conclusions. This study indicates that topical indomethacin solution 0.1% is a useful treatment for inflamed pterygium and pinguecula, (C) Lippincott-Raven Publishers.
@article{frucht-pery_treatment_1997,
	title = {Treatment of {Inflamed} {Pterygium} and {Pinguecula} with {Topical} {Indomethacin} 0.1\% {Solution}},
	volume = {16},
	issn = {0277-3740},
	abstract = {Purpose. To evaluate the effect of topical indomethacin 0.1\% on signs and symptoms in inflamed pterygium and pinguecula. Methods. Fifty-one consecutive patients who had inflamed pterygium (n = 32) or pinguecula (n = 19) were studied in a randomized, double-masked, controlled way. Objective signs (conjunctival congestion, redness, edema, and staining of cornea) and subjective complaints (photophobia, pain, foreign-body sensation, discomfort, and tearing) were evaluated and scored. In addition, we evaluated total signs, total symptoms, and total score. Group I (n = 25) received topical indomethacin 0.1\% solution and group 2 (n = 26) received a placebo six times daily for 3 days, then four times daily for 11 days. Patients were examined before and at days 3, 7, and 14 after the treatment began. Results. In group 1 at day 3, the scores of total signs, total symptoms, and total score decreased (p = 0.001), and they further decreased after 14 days (p = 0.02 to p = 0.05). In group 2 at day 3 these parameters also significantly decreased (p = 0.01 to p = 0.02), but no further improvement occurred after 14 days. Comparing groups I and 2 revealed a decrease in scores in group 1 for total signs, total symptoms, and total score at days 3, 7, and 14 (p = 0.03 to p = 0.002) except for total signs after 14 days (p = NS). All the patients reported mild stinging for {\textless}1 min after administration of the drops. Conclusions. This study indicates that topical indomethacin solution 0.1\% is a useful treatment for inflamed pterygium and pinguecula, (C) Lippincott-Raven Publishers.},
	language = {English.},
	number = {1},
	journal = {Cornea},
	author = {Frucht-Pery, Joseph M. D. and Solomon, Abraham M. D. and Siganos, Charalambos S. M. D. and Shvartzenberg, Tikva M. D. and Richard, Christine M. D. and Trinquand, Claude M. D.},
	month = jan,
	year = {1997},
	keywords = {Inflammation, Pinguecula, Pterygium, Topical indomethacin},
	pages = {42--47},
}

Downloads: 0